May 9 |
Femasys GAAP EPS of -$0.17, revenue of $0.27M
|
May 9 |
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
|
May 9 |
Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
|
May 7 |
Femasys Expands Commercial Management Team with Addition of Experienced New Hires
|
May 2 |
Will Femasys Inc. (FEMY) Report Negative Q1 Earnings? What You Should Know
|
Apr 18 |
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
|
Mar 31 |
Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Mar 28 |
Femasys GAAP EPS of -$0.93, revenue of $1.07M
|
Mar 28 |
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
|
Mar 21 |
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
|